The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | A | Alimentary tract and metabolism | |
| 2 | A10 | Drugs used in diabetes | |
| 3 | A10A | Insulins and analogues | |
| 4 | A10AE | Insulins and analogues for injection, long-acting | |
| 5 | A10AE06 |
| Active Ingredient | Description | |
|---|---|---|
| Insulin degludec |
Insulin degludec binds specifically to the human insulin receptor and results in the same pharmacological effects as human insulin. The blood glucose-lowering effect of insulin is due to the facilitated uptake of glucose following the binding of insulin to receptors on muscle and fat cells and to the simultaneous inhibition of glucose output from the liver. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| TRESIBA Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| TRESIBA Solution for injection | European Medicines Agency (EU) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
